Rare ovarian tumors: an update on diagnosis and treatment

被引:16
作者
Debuquoy, Charlotte [1 ]
Romeo, Clemence [2 ]
Vanacker, Helene [2 ]
Ray-Coquard, Isabelle [2 ,3 ]
机构
[1] Ctr Leon Berard, Gynecol Surg Dept, Lyon, Rhone Alpes, France
[2] Ctr Leon Berard, Med Oncol, Lyon, Rhone Alpes, France
[3] Univ Claude Bernard, Lab HESPER, Lyon, France
关键词
Ovarian cancer; SMALL-CELL CARCINOMA; GRADE SEROUS OVARIAN; HYPERCALCEMIC TYPE; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; CANCER; WOMEN; IMPACT; LYMPHADENECTOMY; BEVACIZUMAB;
D O I
10.1136/ijgc-2020-001235
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Rare ovarian cancers occur frequently. Almost half of ovarian malignancies relate to several different 'rare' histotypes, according to the World Health Organization. The most common tumors are epithelial tumors, including high grade serous carcinomas, the presumed 'frequent ovarian cancers', together with low grade serous, mucinous, endometrioid, clear cell, and carcinosarcomas. Sex cord stromal tumors and germ cell carcinomas define two other groups of different subtypes, and small cell carcinomas are an independent high grade subtype closely related to the family of rhabdoid tumors. All of these cancers are primary ovarian cancers, classified by the International Federation of Gynecology and Obstetrics. However, the tumor subtypes display various epidemiologic, clinical, pathological, prognostic, and therapeutic characteristics. Because of the scarcity of data, current understanding of each subtype is limited and treatment has generally been derived from the more common tumor types. The aim of this article is to review the current literature on rare ovarian malignancies.
引用
收藏
页码:879 / 887
页数:9
相关论文
共 50 条
  • [41] Epithelioid Hemangioendothelioma: Update on Diagnosis and Treatment
    Rosenberg, Ari
    Agulnik, Mark
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (04)
  • [42] The diagnosis and treatment of PCOS in adolescents: an update
    Witchel, Selma F.
    Burghard, Anne Claire
    Tao, Rachel H.
    Oberfield, Sharon E.
    CURRENT OPINION IN PEDIATRICS, 2019, 31 (04) : 562 - 569
  • [43] UPDATE ON IDIOPATHIC HIRSUTISM: DIAGNOSIS AND TREATMENT
    Erem, C.
    ACTA CLINICA BELGICA, 2013, 68 (04) : 268 - 274
  • [44] Lymphangioleiomyomatosis: Update on Pathophysiology, Diagnosis, and Treatment
    Castillo, Macarena Lagos
    Cartes, Felipe Reyes
    REVISTA MEDICA DE CHILE, 2025, 153 (01) : 63 - 71
  • [45] The usefulness of intraoperative consultation for the diagnosis of borderline ovarian tumors
    Salcedo-Hernandez, Rosa A.
    Cantu-de-Leon, David F.
    Perez-Montiel, Delia
    Garcia-Perez, Leticia
    Lino-Silva, Leonardo S.
    Zepeda-Najar, Cesar
    Barquet-Munoz, Salim A.
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (03)
  • [46] Rare ovarian tumors: a single center experience of 15 years
    Gungor, T.
    Altinkaya, S. O.
    Baser, E.
    Guler, I.
    Uzunlar, O.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2014, 35 (03) : 250 - 258
  • [47] Characteristics of diagnosis and therapy of adolescent malignant ovarian tumors
    Su, M.
    Chang, W.
    Xu, T.
    Cui, M.
    Wu, S.
    Su, P.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2013, 34 (06) : 565 - 568
  • [48] The role of five plasma proteins in the diagnosis of ovarian tumors
    Racheva, Valeria Z.
    Ruseva, Adelaida L.
    Yordanov, Angel D.
    GAZZETTA MEDICA ITALIANA ARCHIVIO PER LE SCIENZE MEDICHE, 2023, 182 (04) : 222 - 230
  • [49] Spectropolarimetry in the differential diagnosis of benign and malignant ovarian tumors
    Peresunko, O. P.
    Yermolenko, S. B.
    Gruia, I.
    THIRTEENTH INTERNATIONAL CONFERENCE ON CORRELATION OPTICS, 2017, 10612
  • [50] Conservative treatment of borderline ovarian tumors: the experience of one clinical center
    Olszewska, Hanna
    Abacjew-Chmylko, Anna
    Sawicki, Sambor
    Olszewski, Jaroslaw
    Wydra, Dariusz Grzegorz
    GINEKOLOGIA POLSKA, 2015, 86 (09) : 653 - 658